These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12392548)

  • 21. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein.
    Hoffman TL; LaBranche CC; Zhang W; Canziani G; Robinson J; Chaiken I; Hoxie JA; Doms RW
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6359-64. PubMed ID: 10339592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines.
    Atchison RE; Gosling J; Monteclaro FS; Franci C; Digilio L; Charo IF; Goldsmith MA
    Science; 1996 Dec; 274(5294):1924-6. PubMed ID: 8943208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An extended CCR5 ECL2 peptide forms a helix that binds HIV-1 gp120 through non-specific hydrophobic interactions.
    Abayev M; Moseri A; Tchaicheeyan O; Kessler N; Arshava B; Naider F; Scherf T; Anglister J
    FEBS J; 2015 May; 282(10):1906-1921. PubMed ID: 25703038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4.
    Zhang W; Godillot AP; Wyatt R; Sodroski J; Chaiken I
    Biochemistry; 2001 Feb; 40(6):1662-70. PubMed ID: 11327825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
    Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
    Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies.
    Liu S; Fan S; Sun Z
    J Mol Model; 2003 Oct; 9(5):329-36. PubMed ID: 14517611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors.
    Zaitseva M; Peden K; Golding H
    Biochim Biophys Acta; 2003 Jul; 1614(1):51-61. PubMed ID: 12873765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibody screening of a phage-displayed random peptide library reveals mimotopes of chemokine receptor CCR5: implications for the tertiary structure of the receptor and for an N-terminal binding site for HIV-1 gp120.
    Königs C; Rowley MJ; Thompson P; Myers MA; Scealy M; Davies JM; Wu L; Dietrich U; Mackay CR; Mackay IR
    Eur J Immunol; 2000 Apr; 30(4):1162-71. PubMed ID: 10760806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of basic residues and quaternary structure in the function of MIP-1 beta: CCR5 binding and cell surface sugar interactions.
    Laurence JS; Blanpain C; De Leener A; Parmentier M; LiWang PJ
    Biochemistry; 2001 Apr; 40(16):4990-9. PubMed ID: 11305915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120.
    Binley JM; Ngo-Abdalla S; Moore P; Bobardt M; Chatterji U; Gallay P; Burton DR; Wilson IA; Elder JH; de Parseval A
    Retrovirology; 2006 Jul; 3():39. PubMed ID: 16817962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and functional activity of CXCR-4 and CCR-5 chemokine receptors in human thymocytes.
    Zamarchi R; Allavena P; Borsetti A; Stievano L; Tosello V; Marcato N; Esposito G; Roni V; Paganin C; Bianchi G; Titti F; Verani P; Gerosa G; Amadori A
    Clin Exp Immunol; 2002 Feb; 127(2):321-30. PubMed ID: 11876757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the Physicochemical and Structural Modifications Associated with HIV-1 Subtype B Tropism Transition.
    Lamers SL; Fogel GB; Liu ES; Salemi M; McGrath MS
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):829-40. PubMed ID: 27071630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A functional, discontinuous HIV-1 gp120 C3/C4 domain-derived, branched, synthetic peptide that binds to CD4 and inhibits MIP-1alpha chemokine binding.
    Howie SE; Fernandes ML; Heslop I; Hewson TJ; Cotton GJ; Moore MJ; Innes D; Ramage R; Harrison DJ
    FASEB J; 1999 Mar; 13(3):503-11. PubMed ID: 10064617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferential targeting of CD4-CCR5 complexes with bifunctional inhibitors: a novel approach to block HIV-1 infection.
    Mack M; Pfirstinger J; Haas J; Nelson PJ; Kufer P; Riethmüller G; Schlöndorff D
    J Immunol; 2005 Dec; 175(11):7586-93. PubMed ID: 16301668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple determinants are involved in HIV coreceptor use as demonstrated by CCR4/CCL22 interaction in peripheral blood mononuclear cells (PBMCs).
    Agrawal L; Vanhorn-Ali Z; Alkhatib G
    J Leukoc Biol; 2002 Nov; 72(5):1063-74. PubMed ID: 12429730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1.
    Kuhmann SE; Platt EJ; Kozak SL; Kabat D
    J Virol; 2000 Aug; 74(15):7005-15. PubMed ID: 10888639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell derived liposomes expressing CCR5 as a new targeted drug-delivery system for HIV infected cells.
    Bronshtein T; Toledano N; Danino D; Pollack S; Machluf M
    J Control Release; 2011 Apr; 151(2):139-48. PubMed ID: 21362450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular modeling on human CCR5 receptors and complex with CD4 antigens and HIV-1 envelope glycoprotein gp120.
    Yang J; Liu CQ
    Acta Pharmacol Sin; 2000 Jan; 21(1):29-34. PubMed ID: 11263244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5.
    Raja A; Venturi M; Kwong P; Sodroski J
    J Virol; 2003 Jan; 77(1):713-8. PubMed ID: 12477875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES.
    Nisius L; Rogowski M; Vangelista L; Grzesiek S
    Protein Expr Purif; 2008 Oct; 61(2):155-62. PubMed ID: 18588983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.